Clifford Chance

Clifford Chance advises 3i portfolio company, Asia Strategic MedTech Holdings on sale of LHi Technology to US firm Carlisle

Clifford Chance has advised Asia Strategic MedTech Holdings, a 3i portfolio company, on the sale of LHi Technology for US$195 million to US-based Carlisle Companies Incorporated.

LHi Technology is a leading medical cables manufacturer, focused on the production of patient monitoring and surgical cable interconnects and assemblies. It is a major supplier to the growing global medical assemblies market and is the only Asia-based supplier to develop, manufacture and sell medical cable assemblies exclusively to medical device companies and original equipment manufacturers internationally.

"We're pleased to have advised 3i on a successful exit following its acquisition of LHI Technology in 2008 on which we also advised 3i," said Singapore Corporate partner Lee Taylor who led on the deal. "The private equity mid-market space has been quite active and we expect this to continue as more players are setting up funds targeting this sweet-spot."

Lee was assisted by Singapore associate Calum McKeen and London antitrust partner Jenine Hulsmann.

3i Group plc is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. It has offices in 9 countries across the Americas, Asia and Europe and has total assets under management of £12.9 billion as at 31 March 2014.